首页 > 最新文献

Chang Gung medical journal最新文献

英文 中文
Serum HCV RNA level is not associated with insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infection. 慢性丙型肝炎1型或2型感染患者血清HCV RNA水平与胰岛素抵抗和代谢综合征无关。
Pub Date : 2011-09-01
Hao-Chun Huang, Chia-Sheng Chuang, Yung-Yu Hsieh, Te-Sheng Chang, Kuo-Liang Wei, Chien-Heng Shen, Cheng-Shyong Wu, Shui-Yi Tung

Background: Previous reports have indicated that insulin resistance (IR) is associated with chronic hepatits C virus (HCV) infection. However, the correlations between IR, metabolic syndrome (MS), and serum HCV RNA levels are still controversial. The aim of this study was to determine the relationships between IR, MS, and HCV RNA in patients with chronic genotype 1 or 2 HCV infection.

Methods: One hundred and twenty subjects with chronic genotype 1 or 2 HCV infection with complete clinical data were prospectively enrolled. Baseline and laboratory data were collected and analyzed. IR was defined as a homeostatic model assessment- IR (HOMA-IR) score > 2.5.

Results: Of the 120 patients, 47 (39.2%) had a HOMA-IR > 2.5, and 42 (35%) met the criteria for MS. IR was significantly associated with a high body mass index (p < 0.0001), high waist circumference (p < 0.0001) and high triglyceride level (p = 0.025). IR was an independent predictor of MS. However, in multivariate linear regression analysis, the serum HCV RNA level was not significantly different in chronic hepatitis C patients with or without IR (p = 0.761), and with or without MS (p = 0.292).

Conclusions: IR and MS are not uncommon in patients with chronic hepatitis C. The serum HCV RNA level is not associated with the presence of IR or MS in chronic hepatitis C patients with genotype 1 or 2 infection. The impact of hepatitis C virus on IR is not dose responsive.

背景:以往的报道表明,胰岛素抵抗(IR)与慢性丙型肝炎病毒(HCV)感染有关。然而,IR、代谢综合征(MS)和血清HCV RNA水平之间的相关性仍然存在争议。本研究的目的是确定慢性基因型1或2型HCV感染患者的IR、MS和HCV RNA之间的关系。方法:前瞻性纳入120例临床资料完整的慢性基因1型或2型HCV感染患者。收集和分析基线和实验室数据。IR定义为稳态模型评估-IR (HOMA-IR)评分> 2.5。结果:在120例患者中,47例(39.2%)HOMA-IR > 2.5, 42例(35%)符合ms标准,IR与高体重指数(p < 0.0001)、高腰围(p < 0.0001)和高甘油三酯水平(p = 0.025)显著相关。IR是MS的独立预测因子,然而,在多变量线性回归分析中,慢性丙型肝炎患者血清HCV RNA水平在有或没有IR (p = 0.761)和有或没有MS (p = 0.292)中没有显著差异。结论:IR和MS在慢性丙型肝炎患者中并不罕见。在基因1型或2型感染的慢性丙型肝炎患者中,血清HCV RNA水平与IR或MS的存在无关。丙型肝炎病毒对IR的影响不是剂量反应性的。
{"title":"Serum HCV RNA level is not associated with insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infection.","authors":"Hao-Chun Huang,&nbsp;Chia-Sheng Chuang,&nbsp;Yung-Yu Hsieh,&nbsp;Te-Sheng Chang,&nbsp;Kuo-Liang Wei,&nbsp;Chien-Heng Shen,&nbsp;Cheng-Shyong Wu,&nbsp;Shui-Yi Tung","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Previous reports have indicated that insulin resistance (IR) is associated with chronic hepatits C virus (HCV) infection. However, the correlations between IR, metabolic syndrome (MS), and serum HCV RNA levels are still controversial. The aim of this study was to determine the relationships between IR, MS, and HCV RNA in patients with chronic genotype 1 or 2 HCV infection.</p><p><strong>Methods: </strong>One hundred and twenty subjects with chronic genotype 1 or 2 HCV infection with complete clinical data were prospectively enrolled. Baseline and laboratory data were collected and analyzed. IR was defined as a homeostatic model assessment- IR (HOMA-IR) score > 2.5.</p><p><strong>Results: </strong>Of the 120 patients, 47 (39.2%) had a HOMA-IR > 2.5, and 42 (35%) met the criteria for MS. IR was significantly associated with a high body mass index (p < 0.0001), high waist circumference (p < 0.0001) and high triglyceride level (p = 0.025). IR was an independent predictor of MS. However, in multivariate linear regression analysis, the serum HCV RNA level was not significantly different in chronic hepatitis C patients with or without IR (p = 0.761), and with or without MS (p = 0.292).</p><p><strong>Conclusions: </strong>IR and MS are not uncommon in patients with chronic hepatitis C. The serum HCV RNA level is not associated with the presence of IR or MS in chronic hepatitis C patients with genotype 1 or 2 infection. The impact of hepatitis C virus on IR is not dose responsive.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30240269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. 膳食多酚作为抗氧化剂和抗癌剂:问题多于答案。
Pub Date : 2011-09-01
Miao-Lin Hu

High intake of fruit and vegetables is believed to be beneficial to human health. Fruit, vegetables and some beverages, such as tea and coffee, are particularly rich in dietary polyphenols. Various studies have suggested (but not proven) that dietary polyphenols may protect against cardiovasucalar diseases, neurodegenerative diseases and some forms of cancer. Dietary polyphenols may exert their anticancer effects through several possible mechanisms, such as removal of carcinogenic agents, modulation of cancer cell signaling and antioxidant enzymatic activities, and induction of apoptosis as well as cell cycle arrest. Some of these effects may be related, at least partly, to their antioxidant activities. In recent years, a new concept of the antioxidant effects of dietary polyphenols has emerged, i.e., direct scavenging activity toward reactive species and indirect antioxidant activity; the latter activity is thought to arise primarily via the activation of nuclear factor-erythroid-2-related factor 2 which stimulates the activities of antioxidant enzymes such as glutathione peroxidase (GPx), glutathione S-transferase, catalase, NAD(P)H: quinone oxidoreductase-1 (NQO1), and/or phase II enzymes. The direct antioxidant activity of dietary polyphenols in vivo is probably limited because of their low concentrations in vivo, except in the gastrointestinal tract where they are present in high concentrations. Paradoxically, the pro-oxidant effect of dietary polyphenols may contribute to the activation of antioxidant enzymes and protective proteins in cultured cells and animal models because of the adaptation of cells and tissues to mild/moderate oxidative stress. Despite a plethora of in vitro studies on dietary polyphenols, many questions remain to be answered, such as: (1) How relevant are the direct and indirect antioxidant activities of dietary polyphenols in vivo? (2) How important are these activities in the anticancer effects of dietary polyphenols? (3) Do the pro-oxidant effects of dietary polyphenols observed in vitro have any relevance in vivo, especially in the potential anticancer effect of dietary polyphenols? Apparently, more carefully-designed in vivo studies are needed to answer these questions.

人们认为大量摄入水果和蔬菜对人体健康有益。水果、蔬菜和一些饮料,如茶和咖啡,特别富含膳食多酚。各种研究表明(但尚未证实),饮食中的多酚可以预防心血管疾病、神经退行性疾病和某些形式的癌症。膳食多酚可能通过几种可能的机制发挥其抗癌作用,如去除致癌物质,调节癌细胞信号和抗氧化酶活性,诱导细胞凋亡和细胞周期阻滞。其中一些效果可能与它们的抗氧化活性有关,至少部分与它们的抗氧化活性有关。近年来出现了一种关于膳食多酚抗氧化作用的新概念,即对活性物质的直接清除作用和间接抗氧化作用;后一种活性被认为主要是通过核因子-红细胞2相关因子2的激活而产生的,该因子2刺激抗氧化酶的活性,如谷胱甘肽过氧化物酶(GPx)、谷胱甘肽s -转移酶、过氧化氢酶、NAD(P)H:醌氧化还原酶-1 (NQO1)和/或II期酶。膳食多酚在体内的直接抗氧化活性可能有限,因为它们在体内的浓度很低,除了在胃肠道中以高浓度存在。矛盾的是,由于细胞和组织对轻度/中度氧化应激的适应,膳食多酚的促氧化作用可能有助于培养细胞和动物模型中抗氧化酶和保护蛋白的激活。尽管对膳食多酚进行了大量的体外研究,但仍有许多问题有待解决,例如:(1)膳食多酚的直接和间接抗氧化活性在体内的相关性如何?(2)这些活性在膳食多酚的抗癌作用中有多重要?(3)在体外观察到的饮食多酚的促氧化作用在体内是否有相关性,特别是饮食多酚的潜在抗癌作用?显然,需要更精心设计的体内研究来回答这些问题。
{"title":"Dietary polyphenols as antioxidants and anticancer agents: more questions than answers.","authors":"Miao-Lin Hu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>High intake of fruit and vegetables is believed to be beneficial to human health. Fruit, vegetables and some beverages, such as tea and coffee, are particularly rich in dietary polyphenols. Various studies have suggested (but not proven) that dietary polyphenols may protect against cardiovasucalar diseases, neurodegenerative diseases and some forms of cancer. Dietary polyphenols may exert their anticancer effects through several possible mechanisms, such as removal of carcinogenic agents, modulation of cancer cell signaling and antioxidant enzymatic activities, and induction of apoptosis as well as cell cycle arrest. Some of these effects may be related, at least partly, to their antioxidant activities. In recent years, a new concept of the antioxidant effects of dietary polyphenols has emerged, i.e., direct scavenging activity toward reactive species and indirect antioxidant activity; the latter activity is thought to arise primarily via the activation of nuclear factor-erythroid-2-related factor 2 which stimulates the activities of antioxidant enzymes such as glutathione peroxidase (GPx), glutathione S-transferase, catalase, NAD(P)H: quinone oxidoreductase-1 (NQO1), and/or phase II enzymes. The direct antioxidant activity of dietary polyphenols in vivo is probably limited because of their low concentrations in vivo, except in the gastrointestinal tract where they are present in high concentrations. Paradoxically, the pro-oxidant effect of dietary polyphenols may contribute to the activation of antioxidant enzymes and protective proteins in cultured cells and animal models because of the adaptation of cells and tissues to mild/moderate oxidative stress. Despite a plethora of in vitro studies on dietary polyphenols, many questions remain to be answered, such as: (1) How relevant are the direct and indirect antioxidant activities of dietary polyphenols in vivo? (2) How important are these activities in the anticancer effects of dietary polyphenols? (3) Do the pro-oxidant effects of dietary polyphenols observed in vitro have any relevance in vivo, especially in the potential anticancer effect of dietary polyphenols? Apparently, more carefully-designed in vivo studies are needed to answer these questions.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30239199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications of hip fractures in children. 儿童髋部骨折的并发症。
Pub Date : 2011-09-01
Feng-Chih Kuo, Shu-Jui Kuo, Jih-Yang Ko, To Wong

Background: Hip fractures account for < 1% of all pediatric fractures. Most are caused by a high-energy mechanism. Complications occur at a high rate because the vascular and osseous anatomy of the child's proximal femur is vulnerable to injury. The purposes of this study were to evaluate whether osteonecrosis influences the functional results and to analyze the risk factors for the development of osteonecrosis.

Methods: We conducted a retrospective review of the complications of hip fractures (3 transepiphyseal fractures, 13 transcervical fractures, 6 cervico-trochanteric fractures, and 1 intertrochanteric fracture) in 23 patients (15 boys and 8 girls) between January 1988 and December 1997. Most injuries were caused by falling from a height or a motorcycle accident. The medical records and serial radiographs of all patients were reviewed. The function of the injured site was evaluated using Ratliff's criteria.

Results: The ages of these children at the time of injury ranged from 1.5 to 16 years (average 11.1 years). The mean follow-up was 4.91 years (range, 1 year to 12 years and 7 months). Overall, complications included osteonecrosis in 11 (48%) patients, premature physeal closure in 11 (48%), coxa vara in 3 (13%) and coxa valga in 2 (9%). There was no nonunion. Poor outcomes were related to the development of osteonecrosis. The time to surgery (≤ 12 hours) and the quality of reduction significantly influenced the occurrence of osteonecrosis. The occurrence and severity of femoral head osteonecrosis significantly influenced the functional results (p < 0.001, and p < 0.048, respectively).

Conclusion: Osteonecrosis is the most severe complication after hip fractures in children and is associated with poor functional results. The time to surgery and the quality of reduction were the significant predictors in our study.

背景:髋部骨折占所有儿童骨折的1%以下。大多数是由高能机制引起的。并发症的发生率很高,因为儿童股骨近端血管和骨性解剖结构易受损伤。本研究的目的是评估骨坏死是否影响功能结果,并分析骨坏死发生的危险因素。方法:对1988年1月至1997年12月23例(男15例,女8例)髋部骨折并发症(3例经骺端骨折,13例经颈椎骨折,6例颈粗隆骨折,1例粗隆间骨折)进行回顾性分析。大多数受伤是由从高处坠落或摩托车事故造成的。回顾了所有患者的病历和系列x线片。采用Ratliff标准评价损伤部位的功能。结果:患儿损伤时年龄在1.5 ~ 16岁之间,平均11.1岁。平均随访时间4.91年(1年至12年7个月)。总的来说,并发症包括11例(48%)患者骨坏死,11例(48%)患者骨骺过早闭合,3例(13%)患者髋内翻,2例(9%)患者髋外翻。没有工会。不良预后与骨坏死的发生有关。手术时间(≤12小时)和复位质量对骨坏死的发生有显著影响。股骨头坏死的发生和严重程度对功能结果有显著影响(p < 0.001, p < 0.048)。结论:骨坏死是儿童髋部骨折后最严重的并发症,并伴有较差的功能效果。手术时间和复位质量是我们研究中重要的预测因素。
{"title":"Complications of hip fractures in children.","authors":"Feng-Chih Kuo,&nbsp;Shu-Jui Kuo,&nbsp;Jih-Yang Ko,&nbsp;To Wong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Hip fractures account for < 1% of all pediatric fractures. Most are caused by a high-energy mechanism. Complications occur at a high rate because the vascular and osseous anatomy of the child's proximal femur is vulnerable to injury. The purposes of this study were to evaluate whether osteonecrosis influences the functional results and to analyze the risk factors for the development of osteonecrosis.</p><p><strong>Methods: </strong>We conducted a retrospective review of the complications of hip fractures (3 transepiphyseal fractures, 13 transcervical fractures, 6 cervico-trochanteric fractures, and 1 intertrochanteric fracture) in 23 patients (15 boys and 8 girls) between January 1988 and December 1997. Most injuries were caused by falling from a height or a motorcycle accident. The medical records and serial radiographs of all patients were reviewed. The function of the injured site was evaluated using Ratliff's criteria.</p><p><strong>Results: </strong>The ages of these children at the time of injury ranged from 1.5 to 16 years (average 11.1 years). The mean follow-up was 4.91 years (range, 1 year to 12 years and 7 months). Overall, complications included osteonecrosis in 11 (48%) patients, premature physeal closure in 11 (48%), coxa vara in 3 (13%) and coxa valga in 2 (9%). There was no nonunion. Poor outcomes were related to the development of osteonecrosis. The time to surgery (≤ 12 hours) and the quality of reduction significantly influenced the occurrence of osteonecrosis. The occurrence and severity of femoral head osteonecrosis significantly influenced the functional results (p < 0.001, and p < 0.048, respectively).</p><p><strong>Conclusion: </strong>Osteonecrosis is the most severe complication after hip fractures in children and is associated with poor functional results. The time to surgery and the quality of reduction were the significant predictors in our study.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30239205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ruptured aneurysm of the accessory middle cerebral artery associated with moyamoya disease: a case report. 烟雾病合并大脑副中动脉动脉瘤破裂1例。
Pub Date : 2011-09-01
Cheng-Chi Lee, Zhuo-Hao Liu, Shih-Ming Jung, Tao-Chieh Yang

The accessory middle cerebral artery can provide collateral blood supply in moyamoya disease. We report a case of unilateral moyamoya disease which demonstrates the anatomy of the right accessory middle cerebral artery and a ruptured peripheral aneurysm on the artery. Our patient was a 56-year-old woman who initially suffered from headache and lethargy. Right caudate nucleus hemorrhage with intraventricular extension and spontaneous subarachnoid hemorrhage were found on brain computed tomography. A ruptured peripheral accessory middle cerebral artery aneurysm associated with unilateral moyamoya disease was diagnosed on cerebral angiography. Surgical intervention to excise the peripheral accessory middle cerebral artery aneurysm assisted by frameless navigation guidance to reduce the risk of damage to collateral vessels was done successfully. Histopathology of excised tissue showed this anomaly was a pseudoaneurysm. The management of an aneurysm in moyamoya disease should be modified based on its location and collateral vessels. Prevention of aneurysm bleeding and preservation of collateral vessels during craniotomy are the critical when managing hemorrhagic moyamoya disease. This case suggests that surgical intervention for ruptured intracranial aneurysms is safe with the use of frameless navigation guidance to minimize collateral vessel injuries.

烟雾病患者大脑副中动脉可提供侧支血供。我们报告一例单侧烟雾病,显示右侧附属大脑中动脉的解剖和动脉上破裂的外周动脉瘤。我们的病人是一名56岁的女性,最初患有头痛和嗜睡。脑ct显示右侧尾状核出血伴脑室内延伸及自发性蛛网膜下腔出血。在脑血管造影上诊断为单侧烟雾病并发的外周副大脑中动脉瘤破裂。在无框导航引导下成功切除大脑中动脉外周副动脉瘤,降低侧支血管损伤风险。切除组织的组织病理学显示此异常为假性动脉瘤。烟雾病动脉瘤的处理应根据其位置和侧支血管进行调整。在开颅术中预防动脉瘤出血和保存侧支血管是处理出血性烟雾病的关键。本病例提示颅内动脉瘤破裂的手术干预是安全的,使用无框架导航引导以减少侧支血管损伤。
{"title":"Ruptured aneurysm of the accessory middle cerebral artery associated with moyamoya disease: a case report.","authors":"Cheng-Chi Lee,&nbsp;Zhuo-Hao Liu,&nbsp;Shih-Ming Jung,&nbsp;Tao-Chieh Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The accessory middle cerebral artery can provide collateral blood supply in moyamoya disease. We report a case of unilateral moyamoya disease which demonstrates the anatomy of the right accessory middle cerebral artery and a ruptured peripheral aneurysm on the artery. Our patient was a 56-year-old woman who initially suffered from headache and lethargy. Right caudate nucleus hemorrhage with intraventricular extension and spontaneous subarachnoid hemorrhage were found on brain computed tomography. A ruptured peripheral accessory middle cerebral artery aneurysm associated with unilateral moyamoya disease was diagnosed on cerebral angiography. Surgical intervention to excise the peripheral accessory middle cerebral artery aneurysm assisted by frameless navigation guidance to reduce the risk of damage to collateral vessels was done successfully. Histopathology of excised tissue showed this anomaly was a pseudoaneurysm. The management of an aneurysm in moyamoya disease should be modified based on its location and collateral vessels. Prevention of aneurysm bleeding and preservation of collateral vessels during craniotomy are the critical when managing hemorrhagic moyamoya disease. This case suggests that surgical intervention for ruptured intracranial aneurysms is safe with the use of frameless navigation guidance to minimize collateral vessel injuries.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30240758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluoroquinolone-associated tendinopathy. Fluoroquinolone-associated病变。
Pub Date : 2011-09-01
Wen-Chung Tsai, Yun-Ming Yang

The fluoroquinolones (FQs) are used to treat a wide range of infections because of their excellent gastrointestinal absorption, superior tissue penetration and broad-spectrum activity. Recently, FQ-associated tendinopathy and tendon rupture have been reported, especially in the elderly and patients with diabetes and renal failure. However, these adverse effects do not appear to be widely known among physicians. Because of the frequent use of FQs in clinical practice, physicians should be aware of their potential for severe disability from tendon rupture. Achilles tendinopathy or rupture is among the most serious side effects associated with FQ use, with reports markedly increasing, especially with the use of ciprofloxacin. The histopathologic findings include degenerative lesions, fissures, interstitial edema without cellular infiltration, necrosis and neovascularization. There are possible molecular mechanisms accounting for FQ-associated tendinopathy. First, ciprofloxacin mediates inhibition of cell proliferation and G2/M cell cycle arrest in tendon cells by down-regulation of cyclin B and cyclin-dependent kinase 1. Second, ciprofloxacin inhibits the spead and migration of tenocytes by down-regulation of focal adhesion kinase phosphorylation. Third, ciprofloxacin enhances the enzymatic activity of matrix metalloproteinase-2 with degradation of type I collagen. Management of FQ-associated tendinopathy includes immediate discontinuation of FQs, rest, non-steroidal anti-inflammatory drugs, physical modalities and eccentric strengthening exercise. Tendon rupture may require surgical intervention.

氟喹诺酮类药物因其良好的胃肠道吸收、良好的组织穿透性和广谱活性而被用于治疗各种感染。最近,fq相关的肌腱病变和肌腱断裂已被报道,特别是在老年人和糖尿病和肾衰竭患者中。然而,这些副作用在医生中似乎并不广为人知。由于FQs在临床实践中经常使用,医生应该意识到它们可能因肌腱断裂而导致严重残疾。跟腱病变或断裂是使用FQ最严重的副作用之一,相关报道显著增加,特别是使用环丙沙星。组织病理学表现为退行性病变、裂隙、间质水肿,无细胞浸润、坏死和新生血管。fq相关的肌腱病变可能存在分子机制。首先,环丙沙星通过下调周期蛋白B和周期蛋白依赖性激酶1介导肌腱细胞增殖抑制和G2/M细胞周期阻滞。其次,环丙沙星通过下调黏附激酶磷酸化抑制细胞的扩散和迁移。第三,环丙沙星提高基质金属蛋白酶-2的酶活性,降解I型胶原。fq相关肌腱病变的管理包括立即停用fq、休息、非甾体抗炎药、物理模式和偏心强化运动。肌腱断裂可能需要手术干预。
{"title":"Fluoroquinolone-associated tendinopathy.","authors":"Wen-Chung Tsai,&nbsp;Yun-Ming Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The fluoroquinolones (FQs) are used to treat a wide range of infections because of their excellent gastrointestinal absorption, superior tissue penetration and broad-spectrum activity. Recently, FQ-associated tendinopathy and tendon rupture have been reported, especially in the elderly and patients with diabetes and renal failure. However, these adverse effects do not appear to be widely known among physicians. Because of the frequent use of FQs in clinical practice, physicians should be aware of their potential for severe disability from tendon rupture. Achilles tendinopathy or rupture is among the most serious side effects associated with FQ use, with reports markedly increasing, especially with the use of ciprofloxacin. The histopathologic findings include degenerative lesions, fissures, interstitial edema without cellular infiltration, necrosis and neovascularization. There are possible molecular mechanisms accounting for FQ-associated tendinopathy. First, ciprofloxacin mediates inhibition of cell proliferation and G2/M cell cycle arrest in tendon cells by down-regulation of cyclin B and cyclin-dependent kinase 1. Second, ciprofloxacin inhibits the spead and migration of tenocytes by down-regulation of focal adhesion kinase phosphorylation. Third, ciprofloxacin enhances the enzymatic activity of matrix metalloproteinase-2 with degradation of type I collagen. Management of FQ-associated tendinopathy includes immediate discontinuation of FQs, rest, non-steroidal anti-inflammatory drugs, physical modalities and eccentric strengthening exercise. Tendon rupture may require surgical intervention.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30239200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma. 转移性恶性黑色素瘤患者联合卡莫司汀、顺铂、达卡巴嗪、他莫昔芬和低剂量白介素-2的生物化疗。
Pub Date : 2011-09-01
Po-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, Hsien-Kun Chang, Hung-Ming Wang, Tsia-Sheng Yang, Yung-Chang Lin, Chi-Ting Liau, Hsin-Yi Yang, Kun-Yun Yeh, Ming-Mo Ho, Nai-Jun Chang, Cheng-Hsu Wang, John Wen-Chen Chang

Background: The toxicity and efficacy of biochemotherapy with low-dose interleukin-2 for patients with metastatic malignant melanoma (MM) were studied.

Method: Metastatic chemo-naive MM patients were given biochemotherapy (BCDT regimen) with carmustine (BCNU), cisplatin (CDDP), dacarbazine (DTIC), and tamoxifen and interleukin-2 (IL-2) 18 Million International Units in divided doses by subcutaneous injection three times a week for four weeks. BCDT consisted of BCNU (150 mg/m2, day l every 8 weeks), CDDP (25 mg/m2, days l-3 every 4 weeks), DTIC (220 mg/m2, days 1-3 every 4 weeks) and tamoxifen 10 mg twice a day. Treatment was repeated for a total of 6 cycles, or until disease progression or unbearable toxicity.

Results: From Nov 2001 to July 2005, 40 patients (20 men; 20 women) were enrolled. Their median age was 54 years (range 22-79 years). Subtypes of melanoma included 23 (57.5%) acral lentiginous, 11 (27.5%) nodular, 1 (2.5%) mucosal, and 5 (12.5%) others. Grade 3-4 toxicities included neutropenia (27.5%), anemia (45%), and thrombocytopenia (40%). Constitutional IL-2 toxicities included indurate injection site (57.5%), fever (60%), chills (55%), itchy skin (42.5%), bone pain (32.5%) and myalgia (45%). Grade 1-2 hypotension was noted in 12.5% of patients. Eosinophilia (range 5% to 71%) was evident in 72.5% of patients. The response rate was 32.5% including 5% with a complete response, 27.5% with a partial response, and 17.5% with stable disease. The median progression-free survival was 6.2 months (95% CI: 2.9~9.6 months). The median overall survival was 11.3 months (95% CI: 7.0~15.6 months). Five patients (12.5%) who presented with oligo-metastasis achieved five-year survivals.

Conclusions: Our data demonstrated that low-dose IL-2 plus BCDT is tolerable. A durable response and long-term survival can be achieved in a small subgroup of patients.

背景:研究低剂量白介素-2生物化疗对转移性恶性黑色素瘤(MM)患者的毒性和疗效。方法:转移性化疗初治MM患者给予卡莫司汀(BCNU)、顺铂(CDDP)、达卡巴嗪(DTIC)、他莫昔芬和白细胞介素-2 (IL-2) 1800万国际单位分次皮下注射的生物化疗(BCDT方案),每周3次,连续4周。BCDT包括BCNU (150 mg/m2,每8周第1天)、CDDP (25 mg/m2,每4周第1-3天)、DTIC (220 mg/m2,每4周第1-3天)和他莫昔芬10 mg,每天2次。重复治疗共6个周期,或直到疾病进展或无法忍受的毒性。结果:2001年11月至2005年7月共收治40例患者,其中男性20例;20名女性)入选。他们的中位年龄为54岁(22-79岁)。黑色素瘤亚型包括肢端小晶状体型23例(57.5%),结节型11例(27.5%),粘膜型1例(2.5%),其他5例(12.5%)。3-4级毒性包括中性粒细胞减少症(27.5%)、贫血(45%)和血小板减少症(40%)。构成性IL-2毒性包括硬化注射部位(57.5%)、发热(60%)、寒战(55%)、皮肤瘙痒(42.5%)、骨痛(32.5%)和肌痛(45%)。12.5%的患者出现1-2级低血压。72.5%的患者有明显的嗜酸性粒细胞增多(范围5% - 71%)。缓解率为32.5%,其中5%为完全缓解,27.5%为部分缓解,17.5%为病情稳定。中位无进展生存期为6.2个月(95% CI: 2.9~9.6个月)。中位总生存期为11.3个月(95% CI: 7.0~15.6个月)。出现少转移的5例患者(12.5%)达到了5年生存率。结论:我们的数据表明,低剂量IL-2 + BCDT是可耐受的。在一小部分患者中可以获得持久的反应和长期的生存。
{"title":"Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma.","authors":"Po-Jung Su,&nbsp;Jen-Shi Chen,&nbsp;Chuang-Chi Liaw,&nbsp;Hsien-Kun Chang,&nbsp;Hung-Ming Wang,&nbsp;Tsia-Sheng Yang,&nbsp;Yung-Chang Lin,&nbsp;Chi-Ting Liau,&nbsp;Hsin-Yi Yang,&nbsp;Kun-Yun Yeh,&nbsp;Ming-Mo Ho,&nbsp;Nai-Jun Chang,&nbsp;Cheng-Hsu Wang,&nbsp;John Wen-Chen Chang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The toxicity and efficacy of biochemotherapy with low-dose interleukin-2 for patients with metastatic malignant melanoma (MM) were studied.</p><p><strong>Method: </strong>Metastatic chemo-naive MM patients were given biochemotherapy (BCDT regimen) with carmustine (BCNU), cisplatin (CDDP), dacarbazine (DTIC), and tamoxifen and interleukin-2 (IL-2) 18 Million International Units in divided doses by subcutaneous injection three times a week for four weeks. BCDT consisted of BCNU (150 mg/m2, day l every 8 weeks), CDDP (25 mg/m2, days l-3 every 4 weeks), DTIC (220 mg/m2, days 1-3 every 4 weeks) and tamoxifen 10 mg twice a day. Treatment was repeated for a total of 6 cycles, or until disease progression or unbearable toxicity.</p><p><strong>Results: </strong>From Nov 2001 to July 2005, 40 patients (20 men; 20 women) were enrolled. Their median age was 54 years (range 22-79 years). Subtypes of melanoma included 23 (57.5%) acral lentiginous, 11 (27.5%) nodular, 1 (2.5%) mucosal, and 5 (12.5%) others. Grade 3-4 toxicities included neutropenia (27.5%), anemia (45%), and thrombocytopenia (40%). Constitutional IL-2 toxicities included indurate injection site (57.5%), fever (60%), chills (55%), itchy skin (42.5%), bone pain (32.5%) and myalgia (45%). Grade 1-2 hypotension was noted in 12.5% of patients. Eosinophilia (range 5% to 71%) was evident in 72.5% of patients. The response rate was 32.5% including 5% with a complete response, 27.5% with a partial response, and 17.5% with stable disease. The median progression-free survival was 6.2 months (95% CI: 2.9~9.6 months). The median overall survival was 11.3 months (95% CI: 7.0~15.6 months). Five patients (12.5%) who presented with oligo-metastasis achieved five-year survivals.</p><p><strong>Conclusions: </strong>Our data demonstrated that low-dose IL-2 plus BCDT is tolerable. A durable response and long-term survival can be achieved in a small subgroup of patients.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30239204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amisulpride and neuroleptic malignant syndrome. 氨硫pride与抗精神病药恶性综合征。
Pub Date : 2011-09-01
Ming-Che Tu, Cheng-Cheng Hsiao

Neuroleptic malignant syndrome (NMS) is a rare but lethal complication of neuroleptics. Its incidence ranges between 0.02% and 3%. Amisulpride, a second generation neuroleptic, was associated with rhabdomyolysis in one report and NMS in 2 reports. Although the precise pathogenesis is still unclear, dopamine receptor blockade is theorized to play a central role. Conventional presentations include hyperthermia, muscle rigidity, and elevated creatine kinase concentrations. However, similar to other second generation neuroleptics, amisulpride induces an atypical form of NMS, which presents with lower degrees of hyperthermia and elevation of creatine kinase than the typical form. This phenomenon makes it difficult to identify early signs of NMS. This study describes the first case of amisulprideinduced NMS in Taiwan, together with a review of the current knowledge on NMS. In this case, the correlation between NMS and amisulpride was categorized as "probable" on the Naranjo adverse drug reaction probability scale.

抗精神病药恶性综合征(NMS)是一种罕见但致命的并发症。其发病率在0.02%至3%之间。第二代抗精神病药阿米苏骄傲(Amisulpride)与横纹肌溶解有关的报告有一篇,与NMS有关的报告有两篇。虽然确切的发病机制尚不清楚,但理论上认为多巴胺受体阻断发挥了核心作用。常规表现包括高热、肌肉僵硬和肌酸激酶浓度升高。然而,与其他第二代抗精神病药类似,氨硫pride诱导非典型NMS,其表现为较低的高热程度和肌酸激酶升高。这种现象使得很难识别NMS的早期迹象。本研究报告台湾首例氨硫脲致NMS病例,并对NMS的现有知识进行综述。在本例中,NMS与氨硫pride的相关性在Naranjo药物不良反应概率量表中被归类为“可能”。
{"title":"Amisulpride and neuroleptic malignant syndrome.","authors":"Ming-Che Tu,&nbsp;Cheng-Cheng Hsiao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Neuroleptic malignant syndrome (NMS) is a rare but lethal complication of neuroleptics. Its incidence ranges between 0.02% and 3%. Amisulpride, a second generation neuroleptic, was associated with rhabdomyolysis in one report and NMS in 2 reports. Although the precise pathogenesis is still unclear, dopamine receptor blockade is theorized to play a central role. Conventional presentations include hyperthermia, muscle rigidity, and elevated creatine kinase concentrations. However, similar to other second generation neuroleptics, amisulpride induces an atypical form of NMS, which presents with lower degrees of hyperthermia and elevation of creatine kinase than the typical form. This phenomenon makes it difficult to identify early signs of NMS. This study describes the first case of amisulprideinduced NMS in Taiwan, together with a review of the current knowledge on NMS. In this case, the correlation between NMS and amisulpride was categorized as \"probable\" on the Naranjo adverse drug reaction probability scale.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30240755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. 上尿路上皮癌患者行肾输尿管切除术,适当的膀胱袖切除是否会影响预后?
Pub Date : 2011-09-01
Chen-Pang Hou, Phei-Lang Chang, Chien-Lun Chen, Yu-Hsiang Lin, Ke-Hung Tsui

Background: Nephroureterectomy with bladder cuff excision has been the gold standard surgical treatment for upper tract urothelial carcinoma. In this study, we determined the independent prognostic factors for upper tract urothelial carcinoma.

Methods: The records of 285 consecutive patients undergoing nephroureterectomy with bladder cuff excision at our institution between 2003 and 2007 were reviewed. Kaplan-Meier survival curves were used to determine the 5-year cancer-specific survival rates for all patient groups. Cox proportional hazard regression was performed to determine the factors that had an independent impact on the survival of patients with upper tract urothelial carcinoma.

Results: A total of 192 patients matching the inclusion criteria were enrolled in our study. The mean follow-up time was 43.81 months. We found that the female gender, a lower ureter free of invasion, and an adequate bladder cuff excision were independent factors for a better tumor recurrence-free survival rate. The pathology stage and recurrence (none, intravesical or extravesical) were independent factors for the overall survival rate. A non-adequate ureterectomy including the bladder cuff was associated with a high body mass index (BMI) and the infiltrating tumor pattern of urothelial carcinoma.

Conclusion: Nnephroureterectomy together with adequate bladder cuff excision plays an extremely important role in the surgical treatment of upper urinary tract urothelial carcinoma. Patients with incomplete resections of the bladder cuff are at increased risk of tumor recurrence.

背景:肾输尿管切除术联合膀胱袖切除术已成为治疗上尿路上皮癌的金标准手术方法。在这项研究中,我们确定了上尿路上皮癌的独立预后因素。方法:回顾性分析我院2003 ~ 2007年间行肾输尿管切除术合并膀胱袖切除术的285例患者的临床资料。Kaplan-Meier生存曲线用于确定所有患者组的5年癌症特异性生存率。采用Cox比例风险回归来确定对上尿路上皮癌患者生存有独立影响的因素。结果:共有192例符合纳入标准的患者入组。平均随访时间43.81个月。我们发现女性、输尿管下部无侵及膀胱袖口切除是提高肿瘤无复发生存率的独立因素。病理分期和复发(无复发,膀胱内或膀胱外)是影响总生存率的独立因素。不充分的输尿管切除术包括膀胱袖带与高体重指数(BMI)和尿路上皮癌的浸润性肿瘤模式相关。结论:肾输尿管切除术联合适当的膀胱袖切除术在上尿路尿路上皮癌的手术治疗中起着极其重要的作用。不完全切除膀胱袖的患者肿瘤复发的风险增加。
{"title":"Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.","authors":"Chen-Pang Hou,&nbsp;Phei-Lang Chang,&nbsp;Chien-Lun Chen,&nbsp;Yu-Hsiang Lin,&nbsp;Ke-Hung Tsui","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Nephroureterectomy with bladder cuff excision has been the gold standard surgical treatment for upper tract urothelial carcinoma. In this study, we determined the independent prognostic factors for upper tract urothelial carcinoma.</p><p><strong>Methods: </strong>The records of 285 consecutive patients undergoing nephroureterectomy with bladder cuff excision at our institution between 2003 and 2007 were reviewed. Kaplan-Meier survival curves were used to determine the 5-year cancer-specific survival rates for all patient groups. Cox proportional hazard regression was performed to determine the factors that had an independent impact on the survival of patients with upper tract urothelial carcinoma.</p><p><strong>Results: </strong>A total of 192 patients matching the inclusion criteria were enrolled in our study. The mean follow-up time was 43.81 months. We found that the female gender, a lower ureter free of invasion, and an adequate bladder cuff excision were independent factors for a better tumor recurrence-free survival rate. The pathology stage and recurrence (none, intravesical or extravesical) were independent factors for the overall survival rate. A non-adequate ureterectomy including the bladder cuff was associated with a high body mass index (BMI) and the infiltrating tumor pattern of urothelial carcinoma.</p><p><strong>Conclusion: </strong>Nnephroureterectomy together with adequate bladder cuff excision plays an extremely important role in the surgical treatment of upper urinary tract urothelial carcinoma. Patients with incomplete resections of the bladder cuff are at increased risk of tumor recurrence.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30239202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is a biopsy necessary for colon polyps suitable for polypectomy when performing a colonoscopy? 当进行结肠镜检查时,结肠息肉是否需要活检?
Pub Date : 2011-09-01
Chih-Hung Chen, Keng-Liang Wu, Ming-Luen Hu, Yi-Chun Chiu, Wei-Chen Tai, Shue-Shian Chiou, Seng-Kee Chuah

Background: The incidence of colorectal cancer is increasing in Taiwan. Adenomatous polyps are known to be precancerous lesions and need to be removed. New techniques like chromendoscopy, magnifying endoscopy, narrow band imaging and magnifying endoscopy with flexible spectral imaging color enhancement may improve the accuracy of identifying precancerous polyps but are not widely available in the real world. This study analyzed the conventional biopsy method in diagnosing early colon cancer and the necessity for subsequent surgery after polypectomy.

Methods: From January 2002 to December 2007, 1027 adenomatous polypoid specimens taken from 720 patients who received polypectomy by conventional white light colonoscopy were studied. The pathologic reports of 26 specimens of early cancer or high grade dysplasia from 25 patients were analyzed. Protruding polyps were classified as pedunculated (o-Ip), subpedunculated (o-Isp) and sessile (o-Is).

Results: Fourteen of the 26 specimens were type o-Ip, 10 were type o-Isp, and 2 were type o-Is. The pathologic reports were high grade dysplasia (n = 5), mucosal adenocarcinoma (n = 18) and submucosal adenocarcinoma (n = 3). Among these, 7 lesions from 7 patients received a randomized biopsy instead of immediate polypectomy. Adenoma was reported in 6 of them with only one malignancy detected (false negative rate: 86%). Eight patients received surgery. The mean follow-up period for these patients was 17 months, and none of them had recurrences.

Conclusions: The randomized biopsy method for adenomatous polyps has a high false negative rate for early colon cancer and high grade dysplasia and is therefore not necessary in cases of protruding type polyps which can be removed by polypectomy. An adequate direct polypectomy may completely remove the protruding type of early colon cancer.

背景:台湾结直肠癌的发病率呈上升趋势。腺瘤性息肉是已知的癌前病变,需要切除。染色镜、放大内窥镜、窄带成像和柔性光谱成像彩色增强的放大内窥镜等新技术可能会提高识别癌前息肉的准确性,但在现实世界中尚未广泛应用。本研究分析了常规活检方法对早期结肠癌的诊断及息肉切除术后后续手术的必要性。方法:对2002年1月~ 2007年12月行常规白光结肠镜切除的720例息肉患者的1027份腺瘤样息肉标本进行分析。本文对25例26例早期癌或高度不典型增生患者的病理报告进行了分析。突出息肉分为带梗(o-Ip)、近带梗(o-Isp)和无梗(o-Is)。结果:26例中o-Ip型14例,o-Isp型10例,o- i型2例。病理报告为高度不典型增生(n = 5),粘膜腺癌(n = 18)和粘膜下腺癌(n = 3)。其中,7例患者的7个病变接受了随机活检,而不是立即切除息肉。其中腺瘤6例,仅检出1例恶性肿瘤(假阴性率:86%)。8名患者接受了手术。这些患者的平均随访时间为17个月,无复发。结论:腺瘤性息肉随机活检法对早期结肠癌和高度不典型增生的假阴性率较高,对可通过息肉切除术切除的突出型息肉不需要随机活检。适当的直接息肉切除术可以完全切除早期结肠癌的突出型。
{"title":"Is a biopsy necessary for colon polyps suitable for polypectomy when performing a colonoscopy?","authors":"Chih-Hung Chen,&nbsp;Keng-Liang Wu,&nbsp;Ming-Luen Hu,&nbsp;Yi-Chun Chiu,&nbsp;Wei-Chen Tai,&nbsp;Shue-Shian Chiou,&nbsp;Seng-Kee Chuah","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The incidence of colorectal cancer is increasing in Taiwan. Adenomatous polyps are known to be precancerous lesions and need to be removed. New techniques like chromendoscopy, magnifying endoscopy, narrow band imaging and magnifying endoscopy with flexible spectral imaging color enhancement may improve the accuracy of identifying precancerous polyps but are not widely available in the real world. This study analyzed the conventional biopsy method in diagnosing early colon cancer and the necessity for subsequent surgery after polypectomy.</p><p><strong>Methods: </strong>From January 2002 to December 2007, 1027 adenomatous polypoid specimens taken from 720 patients who received polypectomy by conventional white light colonoscopy were studied. The pathologic reports of 26 specimens of early cancer or high grade dysplasia from 25 patients were analyzed. Protruding polyps were classified as pedunculated (o-Ip), subpedunculated (o-Isp) and sessile (o-Is).</p><p><strong>Results: </strong>Fourteen of the 26 specimens were type o-Ip, 10 were type o-Isp, and 2 were type o-Is. The pathologic reports were high grade dysplasia (n = 5), mucosal adenocarcinoma (n = 18) and submucosal adenocarcinoma (n = 3). Among these, 7 lesions from 7 patients received a randomized biopsy instead of immediate polypectomy. Adenoma was reported in 6 of them with only one malignancy detected (false negative rate: 86%). Eight patients received surgery. The mean follow-up period for these patients was 17 months, and none of them had recurrences.</p><p><strong>Conclusions: </strong>The randomized biopsy method for adenomatous polyps has a high false negative rate for early colon cancer and high grade dysplasia and is therefore not necessary in cases of protruding type polyps which can be removed by polypectomy. An adequate direct polypectomy may completely remove the protruding type of early colon cancer.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30239203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of outcome after open repair of ruptured abdominal aortic aneurysms. 腹主动脉瘤破裂开放性修复术后预后的预测因素。
Pub Date : 2011-09-01
Hao-Jui Li, Tsung-Chi Kao, Dah-Wel Liu, Sheng-Yueh Yu, Po-Jen Ko, Hung-Chang Hsieh

Background: To determine predictors associated with early hospital death, 30-day mortality, and long-term survival after open surgical treatment of ruptured abdominal aortic aneurysms (RAAAs).

Methods: A retrospective chart review of 127 consecutive patients who received open surgical treatment of a RAAA at Chang Gung Memorial Hospital, Taiwan, from February 1994 to May 2007. Data recorded included patient characteristics, medical history, perioperative variables, and outcomes.

Results: There were 104 men and 23 women with a mean age of 70 ∓ 12 years in the analysis. Patients with RAAAs were classified into two groups; 100 (78.7%) patients were classified as group I (hemodynamically stable), and 27 (21.3%) patients were classified as group II (hemodynamically unstable at arrival). The 30-day mortality was 22% for group I and 74.1% for group II. Multivariate analysis identified age > 75 years old (odds ratio [OR], 0.083; 95% confidence interval [CI] 0.02-0.36), hemodynamically unstable state (OR, 0.081; 95% CI 0.016-0.4), blood transfusion > 5 L (OR, 0.14; 95% CI 0.038-0.54), intraperitoneal rupture (OR, 7.2; 95% CI 1.4-36), urine output < 0.5 mL/kg/min (OR, 22; 95% CI 4.6-110), and suprarenal cross-clamping (OR, 0.083; 95% CI 0.019-0.36) as incremental risk factors for 30-day mortality.

Conclusion: Significant predictors of mortality in patients with RAAAs include hemodynamically unstable state, age > 75 years old, intraperitoneal rupture, low intraoperative urine output, and suprarenal cross-clamping.

背景:确定开放性腹主动脉瘤(RAAAs)手术后早期住院死亡、30天死亡率和长期生存的相关预测因素。方法:回顾性分析1994年2月至2007年5月在台湾长庚纪念医院连续行开放手术治疗的127例RAAA患者的资料。记录的数据包括患者特征、病史、围手术期变量和结果。结果:分析中有104名男性和23名女性,平均年龄为70±12岁。raaa患者分为两组;100例(78.7%)患者归为I组(血流动力学稳定),27例(21.3%)患者归为II组(入院时血流动力学不稳定)。1组30天死亡率为22%,2组为74.1%。多因素分析确定年龄> 75岁(优势比[OR], 0.083;95%可信区间[CI] 0.02-0.36),血流动力学不稳定状态(OR, 0.081;95% CI 0.016-0.4),输血> 5l (OR, 0.14;95% CI 0.038-0.54),腹膜内破裂(OR, 7.2;95% CI 1.4-36),尿量< 0.5 mL/kg/min (OR, 22;95% CI 4.6-110)和肾上交叉夹持(OR, 0.083;95% CI 0.019-0.36)为30天死亡率的增量危险因素。结论:RAAAs患者死亡率的重要预测因素包括血流动力学不稳定、年龄> 75岁、腹膜内破裂、术中低尿量和肾上交叉夹持。
{"title":"Predictors of outcome after open repair of ruptured abdominal aortic aneurysms.","authors":"Hao-Jui Li,&nbsp;Tsung-Chi Kao,&nbsp;Dah-Wel Liu,&nbsp;Sheng-Yueh Yu,&nbsp;Po-Jen Ko,&nbsp;Hung-Chang Hsieh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>To determine predictors associated with early hospital death, 30-day mortality, and long-term survival after open surgical treatment of ruptured abdominal aortic aneurysms (RAAAs).</p><p><strong>Methods: </strong>A retrospective chart review of 127 consecutive patients who received open surgical treatment of a RAAA at Chang Gung Memorial Hospital, Taiwan, from February 1994 to May 2007. Data recorded included patient characteristics, medical history, perioperative variables, and outcomes.</p><p><strong>Results: </strong>There were 104 men and 23 women with a mean age of 70 ∓ 12 years in the analysis. Patients with RAAAs were classified into two groups; 100 (78.7%) patients were classified as group I (hemodynamically stable), and 27 (21.3%) patients were classified as group II (hemodynamically unstable at arrival). The 30-day mortality was 22% for group I and 74.1% for group II. Multivariate analysis identified age > 75 years old (odds ratio [OR], 0.083; 95% confidence interval [CI] 0.02-0.36), hemodynamically unstable state (OR, 0.081; 95% CI 0.016-0.4), blood transfusion > 5 L (OR, 0.14; 95% CI 0.038-0.54), intraperitoneal rupture (OR, 7.2; 95% CI 1.4-36), urine output < 0.5 mL/kg/min (OR, 22; 95% CI 4.6-110), and suprarenal cross-clamping (OR, 0.083; 95% CI 0.019-0.36) as incremental risk factors for 30-day mortality.</p><p><strong>Conclusion: </strong>Significant predictors of mortality in patients with RAAAs include hemodynamically unstable state, age > 75 years old, intraperitoneal rupture, low intraoperative urine output, and suprarenal cross-clamping.</p>","PeriodicalId":10018,"journal":{"name":"Chang Gung medical journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30240754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chang Gung medical journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1